We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LRCX:NASDAQLam Research Corporation Analysis

Data as of 2026-05-30 - not real-time

$318.18

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Lam Research is trading at $318.18, comfortably above its 20‑day ($293.11), 50‑day ($263.71) and 200‑day ($192.87) moving averages, and the MACD shows a bullish crossover (line $15.10 vs signal $13.14). The RSI sits at 66, indicating momentum but edging toward overbought territory, while volatility is elevated at 52% over the past 30 days and beta is high at 2.74, suggesting a very reactive price profile. Valuation metrics are stretched: the forward PE of 40 compares unfavorably to the industry average of 41.86, the trailing PE of 60 is well above peers, and the DCF‑derived fair value of $121.41 implies the stock is severely overvalued with a downside bias of –1.4% versus current levels. Fundamentally, the company delivers robust growth – revenue is up 23.8% year‑over‑year, gross margin is ~50%, operating margin ~35%, and ROE is an eye‑popping 66%, supported by strong free cash flow of $4.35 B and a modest payout ratio of 19% (dividend yield 0.33%). Analyst sentiment remains positive, with a consensus “Buy” and a median price target of $315, but that target is already below the market price, limiting upside. The AI‑driven semiconductor boom and expanding demand for advanced chip manufacturing provide a compelling long‑run narrative, even as short‑term price pressures from high valuation and market sentiment pose a risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price trading above fair value and near resistance
  • High beta and volatility increasing downside risk
  • Limited upside given consensus target below current price

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash generation and expanding AI chip demand
  • Valuation compression risk as market re‑prices growth
  • Stable dividend with low payout supporting cash flow durability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular AI‑driven semiconductor equipment demand
  • Exceptional profitability metrics (high margins, ROE)
  • Robust balance sheet with ample cash and manageable debt

Key Metrics & Analysis

Financial Health

Revenue Growth23.80%
Profit Margin30.94%
P/E Ratio60.3
ROE66.76%
ROA22.78%
Debt/Equity35.28
P/B Ratio37.6
Op. Cash Flow$7.0B
Free Cash Flow$4.4B
Industry P/E41.9

Technical Analysis

TrendBullish
RSI66.1
Support$250.12
Resistance$333.33
MA 20$293.11
MA 50$263.71
MA 200$192.87
MACDBullish
VolumeStable
Fear & Greed Index94.07

Valuation

Fair Value$121.41
Target Price$313.69
Upside/Downside-1.41%
GradeOvervalued
TypeGrowth
Dividend Yield0.33%

Risk Assessment

Beta2.74
Volatility52.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.